1.
BMJ Case Rep
; 14(11)2021 Nov 30.
Article
in English
| MEDLINE | ID: covidwho-1546479
ABSTRACT
A 40-year-old man was admitted to our hospital for COVID-19. He had been treated for essential thrombocythemia (ET). He was diagnosed severe illness of COVID-19, oxygen therapy and dexamethasone were administered. There was a possibility of thromboembolic events in this case, apixaban for prophylaxis was added. With these treatments, the patient has made a good recovery, and he was discharged on hospital day 11. There is no standard strategy for prophylaxis of thrombosis in patients with ET, and apixaban could be a clinical benefit for these patients.
Subject(s)
COVID-19 , Thrombocythemia, Essential , Adult , Fibrinolytic Agents/therapeutic use , Humans , Male , Pyrazoles , Pyridones , SARS-CoV-2 , Thrombocythemia, Essential/complications , Thrombocythemia, Essential/drug therapy
2.
Hypertension
; 78(4): 1138-1149, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1369455
ABSTRACT
[Figure: see text].